ガイドライン

(旧版)エビデンスとコンセンサスを統合した潰瘍性大腸炎の診療ガイドライン ―難治性炎症性腸管障害に関する調査研究班 プロジェクト研究グループ

書誌情報
 
推奨ステートメントと解説


4.軽症〜中等症の活動期の全大腸炎・左側大腸炎における緩解導入治療

引用文献

1) Ilnyckyj A, Shanahan F, Anton P A, Cheang M, Bernstein C N. Quantification of the placebo response in ulcerative colitis. Gastroenterology 1997;112:1854-1858.
2) Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gasteroenterol 2004;99:1371-1385.
3) Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(Suppl V):v1-v16.
4) Stevens AC. Sulfasalazine and 5-aminosalicylates in the treatement of inflammatory bowel disease. UpToDate 2004, version 12.3.
5) Sutherland LR, May GR, Shaffer FA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-549.
6) Gisbert JP, Gomollon F, Mate J, Pajares JM. Role of 5-aminosalicylic acid in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci 2002;47:471-488.
7) Sutherland L, Roth D, Beck P, et al. Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis. Cochrane Database Syst Rev Issue 2, 2000
8) Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, Safdi M. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol. 1993;88:1188-97.
9) Munakata A, Yoshida Y, Muto T, et al. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis. J Gastroenterol. 1995 Nov;30 Suppl 8:108-11.
10) Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ. 1989;298(6666):82-6.
11) Robinson M, Hanauer S, Hoop R, Zbrozek A, Wilkinson C. Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Aliment Pharmacol Ther 1994;8:27-34.
12) Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000;95:1263-76.
13) KruisW, Bar-Meir S, Feher J, et al. The optimal dose 5-aminosalicylic acid in active ulcerative colitis; a dose-finding study with newly developed mesalamine. Clin Gastroenterol Hepatol 2003;1:36-43.
14) Farup PG, Hinterleitner TA, Lukas M, et al. Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm Bowel Dis 2001;7:237-42.
15) Vecchi M, Meucci G, Gionchetti P, et al. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study. Aliment Pharmacol Ther 2001;15:251-6.
16) Katz S. Update in medical therapy of ulcerative colitis: a practical approach. J Clin Gastroenterol 2002;34:397-407.
17) Sood A, Midha V, Sood N, Kaushal V, Awasthi G. Methylprednisolone acetate versus oral prednisolone in moderately active ulcerative colitis. Indian J Gastroenterol. 2002;21:11-3.
18) Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology 1975; 69: 96-9.
19) Peppercorn MA. Medical management of ulcerative colitis. UpToDate 2004, version 12.3.
20) Sawada K, Muto T, Shimoyama T, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-21.
21) Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001;16:1-9.
22) Thomas GA, Rhodes J, Ragunath K, et al. Transdermal nicotine compared with oral prdnisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol. 1996;8:769-76.
23) Gilat T, Suissa A, Leichtman G, et al. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial.  J Clin Gastroenterol 1987;9:415-7.
24) Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992;33:922-8.
25) Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992;87:432-7.
26) Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 2002;37(Suppl 14):67-72.

 

書誌情報